Literature DB >> 3110287

Prostaglandin synthesis and release by subpopulations of rat alveolar macrophages.

D B Chandler, J D Fulmer.   

Abstract

Alveolar macrophages are the primary phagocytic cell of lung, but are also capable of a variety of other functions, which include initiating or modulating inflammatory and immune responses through the production of soluble mediators. One such group of mediators is the eicosanoids. Further, recent data indicate that alveolar macrophages are not functionally homogeneous, but are heterogeneous with several subpopulations that differ both morphologically and functionally. Considering the apparent importance of prostaglandin synthesis and release in inflammatory and immune responses, the current study was undertaken to determine whether alveolar macrophage subpopulations differ in their ability to synthesize and release prostaglandin (PG) E, PGI2, and thromboxane A2 after stimulation by calcium ionophore A23187, zymosan, or aggregated IgG. Alveolar macrophages were harvested by bronchoalveolar lavage and were separated into 18 density-defined fractions. Density-defined alveolar macrophages (DD-AM) showed marked heterogeneity in prostaglandin synthesis and release. Maximal PGE synthesis and release was seen as a single peak after calcium ionophore A23187 and zymosan stimulation. In contrast, two peaks in PGE synthesis were seen after aggregated IgG stimulation. PGI2 synthesis was seen as a single peak generated by different DD-AM after calcium ionophore A23187 and zymosan. In contrast, aggregated IgG stimulation of subpopulations exhibited uniform synthesis and release of PGI2. Thromboxane A2 synthesis and release was maximal from a broad range of various DD-AM after calcium ionophore A23187, zymosan, and aggregated IgG stimulation. The results demonstrate that DD-AM are heterogeneous in ability to synthesize and release prostaglandins which is dependent on the stimuli. Therefore, specific subpopulations of alveolar macrophages may be central to the control of the pulmonary inflammatory response through specific eicosanoid synthesis and release.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110287

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.

Authors:  P E Poubelle; D Gingras; C Demers; C Dubois; D Harbour; J Grassi; M Rola-Pleszczynski
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

2.  Alveolar macrophages and eicosanoids but not neutrophils, mediate bronchoconstriction induced by FMLP in the guinea-pig.

Authors:  M A Boukili; M F Bureau; A Lellouch-Tubiana; J Lefort; M T Simon; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

3.  Cyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammation.

Authors:  Hong Li; J Alyce Bradbury; Ryan T Dackor; Matthew L Edin; Joan P Graves; Laura M DeGraff; Ping Ming Wang; Carl D Bortner; Shuichiro Maruoka; Fred B Lih; Donald N Cook; Kenneth B Tomer; Anton M Jetten; Darryl C Zeldin
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

4.  Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB.

Authors:  Hong Li; Matthew L Edin; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Artiom Gruzdev; Jennifer Cheng; Ryan T Dackor; Ping Ming Wang; Carl D Bortner; Stavros Garantziotis; Anton M Jetten; Darryl C Zeldin
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

5.  Productive infection of isolated human alveolar macrophages by respiratory syncytial virus.

Authors:  J R Panuska; N M Cirino; F Midulla; J E Despot; E R McFadden; Y T Huang
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  Reduction of lipopolysaccharide-induced cyclooxygenase-2 expression in diabetic arteries.

Authors:  Yuji Takahashi; Michael Poteser; Munetaka Negoro; Ichiro Wakabayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-20       Impact factor: 3.000

7.  Changes in distribution, morphology, and tumor necrosis factor-alpha secretion of alveolar macrophage subpopulations during the development of bleomycin-induced pulmonary fibrosis.

Authors:  M P Everson; D B Chandler
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

8.  Serum albumin induces iNOS expression and NO production in RAW 267.4 macrophages.

Authors:  Michael Poteser; Ichiro Wakabayashi
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

9.  Alveolar macrophage subpopulations' responsiveness to chemotactic stimuli.

Authors:  A L Brannen; D B Chandler
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.